ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sphingosine-1-Receptor Modulators Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18N8145
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Sphingosine 1 Receptor Modulators Drugs Market Insights Forecast to 2027
BUY CHAPTERS

Global Sphingosine-1-Receptor Modulators Drugs Market Research Report 2025

Code: QYRE-Auto-18N8145
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia Ltd
Sun Pharma
Biocon Ltd.
HEC Pharm Co. Limited

Sphingosine-1-Receptor Modulators Drugs Market Size

The global market for Sphingosine-1-Receptor Modulators Drugs was valued at US$ 4589 million in the year 2024 and is projected to reach a revised size of US$ 7464 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Sphingosine-1-Receptor Modulators Drugs Market

Sphingosine-1-Receptor Modulators Drugs Market

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sphingosine-1-Receptor Modulators Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sphingosine-1-Receptor Modulators Drugs.
The Sphingosine-1-Receptor Modulators Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sphingosine-1-Receptor Modulators Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sphingosine-1-Receptor Modulators Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sphingosine-1-Receptor Modulators Drugs Market Report

Report Metric Details
Report Name Sphingosine-1-Receptor Modulators Drugs Market
Accounted market size in year US$ 4589 million
Forecasted market size in 2031 US$ 7464 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Bristol-Myers Squibb, Johnson & Johnson, Arena Pharmaceuticals, Idorsia, Sun Pharma, Biocon, HEC Pharm Co. Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sphingosine-1-Receptor Modulators Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sphingosine-1-Receptor Modulators Drugs Market growing?

Ans: The Sphingosine-1-Receptor Modulators Drugs Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Sphingosine-1-Receptor Modulators Drugs Market size in 2031?

Ans: The Sphingosine-1-Receptor Modulators Drugs Market size in 2031 will be US$ 7464 million.

Who are the main players in the Sphingosine-1-Receptor Modulators Drugs Market report?

Ans: The main players in the Sphingosine-1-Receptor Modulators Drugs Market are Novartis, Bristol-Myers Squibb, Johnson & Johnson, Arena Pharmaceuticals, Idorsia, Sun Pharma, Biocon, HEC Pharm Co. Limited

What are the Application segmentation covered in the Sphingosine-1-Receptor Modulators Drugs Market report?

Ans: The Applications covered in the Sphingosine-1-Receptor Modulators Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Sphingosine-1-Receptor Modulators Drugs Market report?

Ans: The Types covered in the Sphingosine-1-Receptor Modulators Drugs Market report are Fingolimod, Siponimod, Ozanimod, Other

Recommended Reports

Receptor Modulator Drugs

Rare Disease Therapies

Pharmaceutical and Biotech

1 Sphingosine-1-Receptor Modulators Drugs Market Overview
1.1 Product Definition
1.2 Sphingosine-1-Receptor Modulators Drugs by Type
1.2.1 Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fingolimod
1.2.3 Siponimod
1.2.4 Ozanimod
1.2.5 Other
1.3 Sphingosine-1-Receptor Modulators Drugs by Application
1.3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sphingosine-1-Receptor Modulators Drugs Market Size Estimates and Forecasts
1.4.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue 2020-2031
1.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales 2020-2031
1.4.3 Global Sphingosine-1-Receptor Modulators Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sphingosine-1-Receptor Modulators Drugs Market Competition by Manufacturers
2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sphingosine-1-Receptor Modulators Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sphingosine-1-Receptor Modulators Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Type & Application
2.7 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Date of Enter into This Industry
2.8 Global Sphingosine-1-Receptor Modulators Drugs Market Competitive Situation and Trends
2.8.1 Global Sphingosine-1-Receptor Modulators Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sphingosine-1-Receptor Modulators Drugs Players Market Share by Revenue
2.8.3 Global Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sphingosine-1-Receptor Modulators Drugs Market Scenario by Region
3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2020-2031
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2020-2025
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2026-2031
3.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2020-2031
3.3.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2020-2025
3.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2026-2031
3.4 North America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.4.1 North America Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2031)
3.4.3 North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.5.1 Europe Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2031)
3.5.3 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.7.1 Latin America Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2031)
3.7.3 Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2020-2031)
4.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2020-2025)
4.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2026-2031)
4.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2020-2031)
4.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2020-2031)
4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2020-2025)
4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2026-2031)
4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2020-2031)
5.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2020-2025)
5.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2026-2031)
5.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2020-2031)
5.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2020-2031)
5.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2020-2025)
5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2026-2031)
5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Arena Pharmaceuticals
6.4.1 Arena Pharmaceuticals Company Information
6.4.2 Arena Pharmaceuticals Description and Business Overview
6.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.4.5 Arena Pharmaceuticals Recent Developments/Updates
6.5 Idorsia
6.5.1 Idorsia Company Information
6.5.2 Idorsia Description and Business Overview
6.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.5.5 Idorsia Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Company Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Biocon
6.7.1 Biocon Company Information
6.7.2 Biocon Description and Business Overview
6.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 HEC Pharm Co. Limited
6.8.1 HEC Pharm Co. Limited Company Information
6.8.2 HEC Pharm Co. Limited Description and Business Overview
6.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.8.5 HEC Pharm Co. Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sphingosine-1-Receptor Modulators Drugs Industry Chain Analysis
7.2 Sphingosine-1-Receptor Modulators Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sphingosine-1-Receptor Modulators Drugs Production Mode & Process Analysis
7.4 Sphingosine-1-Receptor Modulators Drugs Sales and Marketing
7.4.1 Sphingosine-1-Receptor Modulators Drugs Sales Channels
7.4.2 Sphingosine-1-Receptor Modulators Drugs Distributors
7.5 Sphingosine-1-Receptor Modulators Drugs Customer Analysis
8 Sphingosine-1-Receptor Modulators Drugs Market Dynamics
8.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
8.2 Sphingosine-1-Receptor Modulators Drugs Market Drivers
8.3 Sphingosine-1-Receptor Modulators Drugs Market Challenges
8.4 Sphingosine-1-Receptor Modulators Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia Ltd
Sun Pharma
Biocon Ltd.
HEC Pharm Co. Limited
List of Tables
 Table 1. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sphingosine-1-Receptor Modulators Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sphingosine-1-Receptor Modulators Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sphingosine-1-Receptor Modulators Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sphingosine-1-Receptor Modulators Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sphingosine-1-Receptor Modulators Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Sphingosine-1-Receptor Modulators Drugs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Information
 Table 76. Bristol-Myers Squibb Description and Business Overview
 Table 77. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product
 Table 79. Bristol-Myers Squibb Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Arena Pharmaceuticals Company Information
 Table 86. Arena Pharmaceuticals Description and Business Overview
 Table 87. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product
 Table 89. Arena Pharmaceuticals Recent Developments/Updates
 Table 90. Idorsia Company Information
 Table 91. Idorsia Description and Business Overview
 Table 92. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Idorsia Sphingosine-1-Receptor Modulators Drugs Product
 Table 94. Idorsia Recent Developments/Updates
 Table 95. Sun Pharma Company Information
 Table 96. Sun Pharma Description and Business Overview
 Table 97. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product
 Table 99. Sun Pharma Recent Developments/Updates
 Table 100. Biocon Company Information
 Table 101. Biocon Description and Business Overview
 Table 102. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biocon Sphingosine-1-Receptor Modulators Drugs Product
 Table 104. Biocon Recent Developments/Updates
 Table 105. HEC Pharm Co. Limited Company Information
 Table 106. HEC Pharm Co. Limited Description and Business Overview
 Table 107. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product
 Table 109. HEC Pharm Co. Limited Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Sphingosine-1-Receptor Modulators Drugs Distributors List
 Table 113. Sphingosine-1-Receptor Modulators Drugs Customers List
 Table 114. Sphingosine-1-Receptor Modulators Drugs Market Trends
 Table 115. Sphingosine-1-Receptor Modulators Drugs Market Drivers
 Table 116. Sphingosine-1-Receptor Modulators Drugs Market Challenges
 Table 117. Sphingosine-1-Receptor Modulators Drugs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sphingosine-1-Receptor Modulators Drugs
 Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Type: 2024 & 2031
 Figure 4. Fingolimod Product Picture
 Figure 5. Siponimod Product Picture
 Figure 6. Ozanimod Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Sphingosine-1-Receptor Modulators Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Sales (2020-2031) & (K Units)
 Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 17. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
 Figure 18. Sphingosine-1-Receptor Modulators Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Sphingosine-1-Receptor Modulators Drugs Players: Market Share by Revenue in Sphingosine-1-Receptor Modulators Drugs in 2024
 Figure 21. Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. United States Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Sphingosine-1-Receptor Modulators Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Sphingosine-1-Receptor Modulators Drugs by Type (2020-2031)
 Figure 57. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Sphingosine-1-Receptor Modulators Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Sphingosine-1-Receptor Modulators Drugs by Application (2020-2031)
 Figure 60. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 61. Sphingosine-1-Receptor Modulators Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Sphingosine 1 Phosphate Receptor 1 Market Insights Forecast to 2030
Global Sphingosine 1 Phosphate Receptor S1PR Modulator Market Research Report 2024
Global S1P Receptor Modulator Drugs Market Research Report 2025
Global Ozanimod Market Research Report 2024
Global GIP 1 Receptor Agonist Market Research Report 2024
Global Endothelin 1 Market Research Report 2024
Global Angiopoietin 1 Receptor Market Research Report 2024
GPCR targeting Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AT1 Receptor Antagonists Market Research Report 2024
Global Lysophosphatidic Acid Receptor 1 Market Research Report 2025
Global FPR1 Activator Market Research Report 2024
Global FPR1 Inhibitor Market Research Report 2024
Global FPR1 Antibody Market Research Report 2024
Global K6PC 5 Market Research Report 2024
Global Leptin Test Kit Market Research Report 2024
APOL1 Mediated Kidney Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polydeoxyribonucleotide PDRN and Polynucleotide PN Market Research Report 2024
Global Ceramide NP Market Research Report 2024
Erythropoietin Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Grade Polydeoxyribonucleotide PDRN Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions